M Alan Menter Selected Research

M Alan Menter Research Topics

17	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 05/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2021 - 05/2016
2	Body Weight (Weight, Body) 08/2020 - 05/2016
2	Psoriatic Arthritis 05/2016 - 04/2006
1	Erythema Ab Igne 01/2021
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 07/2018
1	Skin Diseases (Skin Disease) 07/2018
1	Blindness (Hysterical Blindness) 05/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2008
1	Blepharoptosis (Ptosis, Eyelid) 09/2003
1	Headache (Headaches) 09/2003

5	Biological ProductsIBA 02/2021 - 02/2004
3	Pharmaceutical PreparationsIBA 02/2021 - 05/2014
2	tildrakizumabIBA 02/2021 - 08/2020
2	Etanercept (Enbrel)FDA Link 07/2018 - 05/2008
1	deucravacitinibIBA 02/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 02/2022
1	Coal (Coals)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 08/2020
1	CholesterolIBA 08/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	HDL CholesterolIBA 08/2020
1	Interleukin-17 ReceptorsIBA 09/2018
1	ixekizumabIBA 09/2018
1	secukinumabIBA 09/2018
1	brodalumabIBA 09/2018
1	Monoclonal AntibodiesIBA 09/2018
1	InterleukinsIBA 09/2018
1	Interleukin-17 (Interleukin 17)IBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	tofacitinibIBA 05/2016
1	Janus Kinase InhibitorsIBA 05/2016
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 11/2012
1	RetinoidsIBA 05/2008
1	Acitretin FDA Link 05/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2006
1	Adalimumab (Humira)FDA Link 10/2006
1	Methotrexate (Mexate)FDA LinkGeneric 02/2004
1	Infliximab (Remicade)FDA Link 01/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2003
1	tazarotene (Tazorac)FDA Link 05/2003

6	Therapeutics 02/2018 - 04/2006
1	Biological Therapy 02/2018